The emergence of 3-dimensional organoid technology has significantly advanced the understanding of epithelial stem cell biology within the past decade. Stem cells of the gastrointestinal tract have served as a template for this technology, with initial propagation of mouse intestinal enteroids and colonoids (derived from adult small intestine or colon crypt units, respectively) and subsequent adaptation of these protocols for human tissue.1–4 As such, researchers may now evaluate basic intestinal and/or colonic stem cell properties directly from patient tissue.